NEW YORK - Intelligent Bio Solutions Inc. (NASDAQ:INBS), a medical technology company with a market capitalization of $6.93 million, announced Monday that it will upgrade its Intelligent ...

Intelligent Bio Solutions Inc. (INBS) announced the successful collection of new data that reinforces the performance of its Intelligent Fingerprinting Drug Screening System, which is crucial for its ...

Intelligent Bio Solutions partners with Spjotgard to enhance fingerprint drug testing adoption in Scandinavia, addressing rising demand for non-invasive solutions. Intelligent Bio Solutions Inc.

Omega Laboratories, Inc. (Omega), a leading provider of comprehensive drug testing solutions, announces that its state-of-the-art online Custody and Control Form System (oCCF) has received the ...

Customers identify in-house control, project flexibility, productivity, and cost reductions as key business benefits of fingerprint sweat-based drug testing Construction and manufacturing firms ...

NEW YORK, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing ...

NEW YORK, Oct. 31, 2022 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the "Company”), a life sciences company delivering intelligent, non-invasive, real-time testing solutions, ...

A new AI breakthrough could slash the time it takes to discover life-saving medicines, according to researchers in ...